Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001649989-26-000004
Filing Date
2026-05-27
Accepted
2026-05-27 15:29:11
Documents
1
Period of Report
2026-05-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3104
  Complete submission text file 0001649989-26-000004.txt   4703
Mailing Address 111 S. WOOD AVENUE UNIT #100 ISELIN NJ 08830
Business Address 111 S. WOOD AVENUE UNIT #100 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Issuer) CIK: 0001649989 (see all company filings)

EIN.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 7TH CIRCLE, ZAHRAN ST. ZAHRAN PLAZA BLDG,4TH FLR, PO BOX 142909 AMMAN M2 11844
Business Address
Sukhtian Faisal Ghiath (Reporting) CIK: 0001716033 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37759 | Film No.: 261025729